Erratum: SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. (Diabetes Care (2018) 41 (1543–1556) DOI: 10.2337/dc18-0588)

Research output: Contribution to journalComment/Letter to the editorAcademic


In the article cited above, Fig. 3 was replaced. The data in the HbA1c (%) panel under 8.9 baseline was corrected. The online version of the article ( has been corrected.
Original languageEnglish
Pages (from-to)2015
Number of pages1
JournalDiabetes Care
Issue number10
Publication statusPublished - 1 Oct 2019

Cite this